Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2007 1
2008 1
2009 4
2010 5
2011 6
2012 4
2013 5
2014 6
2015 10
2016 4
2017 8
2018 9
2019 6
2020 5
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Results by year
Filters applied: . Clear all
Page 1
Cannulation strategies for percutaneous extracorporeal membrane oxygenation in adults.
Napp LC, Kühn C, Hoeper MM, Vogel-Claussen J, Haverich A, Schäfer A, Bauersachs J. Napp LC, et al. Clin Res Cardiol. 2016 Apr;105(4):283-96. doi: 10.1007/s00392-015-0941-1. Epub 2015 Nov 25. Clin Res Cardiol. 2016. PMID: 26608160 Free PMC article. Review.
Extracorporeal membrane oxygenation (ECMO) has revolutionized treatment of severe isolated or combined failure of lung and heart. Due to remarkable technical development the frequency of use is growing fast, with increasing adoption by interventional cardiologists independ …
Extracorporeal membrane oxygenation (ECMO) has revolutionized treatment of severe isolated or combined failure of lung and heart. Due …
Normal values for cardiovascular magnetic resonance in adults and children.
Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER, Vogel-Claussen J, Turkbey EB, Williams R, Plein S, Tee M, Eng J, Bluemke DA. Kawel-Boehm N, et al. J Cardiovasc Magn Reson. 2015 Apr 18;17(1):29. doi: 10.1186/s12968-015-0111-7. J Cardiovasc Magn Reson. 2015. PMID: 25928314 Free PMC article. Review.
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
Hilfiker-Kleiner D, Haghikia A, Berliner D, Vogel-Claussen J, Schwab J, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kindermann I, Kühl U, Angermann CE, Schlitt A, Fischer D, Podewski E, Böhm M, Sliwa K, Bauersachs J. Hilfiker-Kleiner D, et al. Eur Heart J. 2017 Sep 14;38(35):2671-2679. doi: 10.1093/eurheartj/ehx355. Eur Heart J. 2017. PMID: 28934837 Free PMC article. Clinical Trial.
No patient in the study needed heart transplantation, LV assist device or died. CONCLUSION: Bromocriptine treatment was associated with high rate of full LV-recovery and low morbidity and mortality in PPCM patients compared with other PPCM cohorts not treated with bromocri …
No patient in the study needed heart transplantation, LV assist device or died. CONCLUSION: Bromocriptine treatment was associated wi …
Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction.
Haghikia A, Schwab J, Vogel-Claussen J, Berliner D, Pfeffer T, König T, Zwadlo C, Moulig VA, Franke A, Schwarzkopf M, Ehlermann P, Pfister R, Michels G, Westenfeld R, Stangl V, Kühl U, Podewski E, Kindermann I, Böhm M, Sliwa K, Hilfiker-Kleiner D, Bauersachs J. Haghikia A, et al. Clin Res Cardiol. 2019 Mar;108(3):290-297. doi: 10.1007/s00392-018-1355-7. Epub 2018 Aug 18. Clin Res Cardiol. 2019. PMID: 30121697 Free PMC article. Clinical Trial.
RESULTS: Reduced RVEF at initial presentation was associated with a lower rate of full cardiac recovery at 6-month follow-up (patients with RV dysfunction: 58% vs. patients with normal RV function: 81%; p = 0.027). ...These findings suggest that bromocriptine in addition t …
RESULTS: Reduced RVEF at initial presentation was associated with a lower rate of full cardiac recovery at 6-month follow-up (patient …
Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial.
Vogel-Claussen J, Schönfeld CO, Kaireit TF, Voskrebenzev A, Czerner CP, Renne J, Tillmann HC, Berschneider K, Hiltl S, Bauersachs J, Welte T, Hohlfeld JM. Vogel-Claussen J, et al. Am J Respir Crit Care Med. 2019 May 1;199(9):1086-1096. doi: 10.1164/rccm.201805-0995OC. Am J Respir Crit Care Med. 2019. PMID: 30641027 Clinical Trial.
Rationale: In the CLAIM study, dual bronchodilation with indacaterol/glycopyrronium (IND/GLY) significantly reduced hyperinflation, which translated into improved cardiac function, measured by left ventricular end-diastolic volume and cardiac output. ...
Rationale: In the CLAIM study, dual bronchodilation with indacaterol/glycopyrronium (IND/GLY) significantly reduced hyperinflation, which tr …
Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial.
Hohlfeld JM, Vogel-Claussen J, Biller H, Berliner D, Berschneider K, Tillmann HC, Hiltl S, Bauersachs J, Welte T. Hohlfeld JM, et al. Lancet Respir Med. 2018 May;6(5):368-378. doi: 10.1016/S2213-2600(18)30054-7. Epub 2018 Feb 21. Lancet Respir Med. 2018. PMID: 29477448 Clinical Trial.
Patients with stable cardiovascular disease were eligible, but those with arrhythmias, heart failure, unstable ischaemic heart disease, or uncontrolled hypertension were not. ...INTERPRETATION: This is the first study to analyse the effect of LABA-LAMA combination t …
Patients with stable cardiovascular disease were eligible, but those with arrhythmias, heart failure, unstable ischaemic heart
ACR Appropriateness Criteria() Dyspnea-Suspected Cardiac Origin.
Expert Panel on Cardiac Imaging:, Vogel-Claussen J, Elshafee ASM, Kirsch J, Brown RKJ, Hurwitz LM, Javidan-Nejad C, Julsrud PR, Kramer CM, Krishnamurthy R, Laroia AT, Leipsic JA, Panchal KK, Shah AB, White RD, Woodard PK, Abbara S. Expert Panel on Cardiac Imaging:, et al. J Am Coll Radiol. 2017 May;14(5S):S127-S137. doi: 10.1016/j.jacr.2017.01.032. J Am Coll Radiol. 2017. PMID: 28473068 Review.
This article discusses imaging guidelines for five dyspnea variants: (1) dyspnea due to heart failure, ischemia not excluded; (2) dyspnea due to suspected nonischemic heart failure, ischemia excluded; (3) dyspnea due to suspected valvular heart disease, ische …
This article discusses imaging guidelines for five dyspnea variants: (1) dyspnea due to heart failure, ischemia not excluded; (2) dys …
Computed tomography evaluation of cardiac valves: a review.
Ketelsen D, Fishman EK, Claussen CD, Vogel-Claussen J. Ketelsen D, et al. Radiol Clin North Am. 2010 Jul;48(4):783-97. doi: 10.1016/j.rcl.2010.04.007. Radiol Clin North Am. 2010. PMID: 20705173 Review.
Electrocardiograph (ECG)-gated cardiac computed tomography (CT) angiography has great potential for the evaluation of the cardiac valves, with excellent image quality. ...A wide range of valve pathology, including congenital and acquired conditions, infectious endoc …
Electrocardiograph (ECG)-gated cardiac computed tomography (CT) angiography has great potential for the evaluation of the cardiac
Chronic thromboembolic pulmonary hypertension.
Olsson KM, Meyer B, Hinrichs J, Vogel-Claussen J, Hoeper MM, Cebotari S. Olsson KM, et al. Dtsch Arztebl Int. 2014 Dec 12;111(50):856-62. doi: 10.3238/arztebl.2014.0856. Dtsch Arztebl Int. 2014. PMID: 25585582 Free PMC article. Review.
On the other hand, confirmation of a positive diagnosis for treatment planning requires right-heart catheterization and pulmonary angiography. The treatment of first choice for CTEPH is surgical pulmonary endarterectomy (PEA), with which about 70% of patients can be cured. …
On the other hand, confirmation of a positive diagnosis for treatment planning requires right-heart catheterization and pulmonary ang …
Separate Origin of Four Major Coronary Arteries.
Richter J, Vogel-Claussen J, Bobylev D, Horke A, Westhoff-Bleck M, Bauersachs J, Napp LC. Richter J, et al. Cardiovasc Revasc Med. 2021 Apr;25:86-88. doi: 10.1016/j.carrev.2020.12.006. Epub 2020 Dec 4. Cardiovasc Revasc Med. 2021. PMID: 33317947 No abstract available.
70 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page